Metropolitan Life Insurance Co. NY trimmed its position in shares of Monsanto (NYSE:MON) by 61.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 87,535 shares of the basic materials company’s stock after selling 140,111 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Monsanto were worth $10,222,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of MON. Macquarie Group Ltd. grew its holdings in shares of Monsanto by 204.0% during the 4th quarter. Macquarie Group Ltd. now owns 121,156 shares of the basic materials company’s stock valued at $14,170,000 after acquiring an additional 81,300 shares in the last quarter. Zeke Capital Advisors LLC grew its position in shares of Monsanto by 50.2% in the 4th quarter. Zeke Capital Advisors LLC now owns 10,488 shares of the basic materials company’s stock valued at $1,225,000 after acquiring an additional 3,503 shares during the period. Flinton Capital Management LLC grew its position in shares of Monsanto by 90.9% in the 4th quarter. Flinton Capital Management LLC now owns 1,764 shares of the basic materials company’s stock valued at $206,000 after acquiring an additional 840 shares during the period. Cornerstone Capital Management Holdings LLC. grew its position in shares of Monsanto by 63.0% in the 4th quarter. Cornerstone Capital Management Holdings LLC. now owns 122,908 shares of the basic materials company’s stock valued at $14,352,000 after acquiring an additional 47,523 shares during the period. Finally, Elkfork Partners LLC bought a new position in shares of Monsanto in the 4th quarter valued at about $162,000. Hedge funds and other institutional investors own 76.21% of the company’s stock.
A number of research analysts have recently commented on MON shares. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Wells Fargo restated a “market perform” rating and set a $128.00 target price (up previously from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Finally, Deutsche Bank restated a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $127.30.
Shares of MON stock opened at $117.15 on Friday. Monsanto has a 12 month low of $113.09 and a 12 month high of $124.20. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05. The firm has a market cap of $51,807.32, a PE ratio of 21.61, a price-to-earnings-growth ratio of 1.69 and a beta of 0.95.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.01). The business had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. Monsanto’s revenue for the quarter was up .3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.21 EPS. equities analysts expect that Monsanto will post 5.73 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.84%. The ex-dividend date is Thursday, April 5th. Monsanto’s payout ratio is presently 39.85%.
In other news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the transaction, the executive vice president now directly owns 56,743 shares in the company, valued at approximately $6,772,277.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.79% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY WARNING: “Monsanto (MON) Stake Lessened by Metropolitan Life Insurance Co. NY” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another domain, it was copied illegally and republished in violation of international copyright & trademark laws. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/03/24/metropolitan-life-insurance-co-ny-has-10-22-million-holdings-in-monsanto-mon.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.